Skip to main content

Table 5 Effects of unfractionated heparin on acute chest syndrome

From: Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome

Outcome

Standard of care

Unfractionated heparin

Mean difference with 95% CI

Duration of hospitalization (h)

127 ± 138

279 ± 268

152 (− 290, 594)

73 (25, 284)

238 (47, 595)

Duration of hypoxemia (h)

51 ± 45

118 ± 61

66 (− 42, 174)

73 (0, 81)

127 (47, 168)

Duration of fever (h)

0 ± 0

25 ± 30

25 (− 33, 162)

0 (0, 0)

20 (0, 59)

Duration of leukocytosis (h)

53 ± 25

118 ± 61

64 (− 33, 162)

61 (25, 73)

127 (47, 168)

Duration of moderate to severe pain (h)

89 ± 73

118 ± 61

29 (− 100, 158)

73 (25, 168)

127 (47, 168)

Total dose of opioids (mg oral morphine equivalents)

1167 ± 1113

3447 ± 4466

2280 (− 4651, 9211)

1786 (317, 9900)

Number of red blood cell transfusions

4

5

 

Transfer to the intensive care unit

1 (33%)

0 (0%)

 

Mechanical ventilation

0 (0%)

0 (0%)

 

Multiorgan dysfunction syndrome

0 (0%)

0 (0%)

 
  1. n (%) for categorical variables. Mean ± SD and median (Min, Max) for continuous variables